アフターアワーズ： 221.00

Cencora Inc (COR)

Cencora Inc (COR) 最新ニュース

Cencora Inc (COR)

Cencora Inc (COR) 最新ニュース

Cencora Provides Notice of Data Breach Affecting Bristol Myers Squibb Customers’ Information - JD Supra

Cencora Data Breach Results in Leak of Confidential Information Provided to PTC Therapeutics, Inc. - JD Supra

Cencora Data Breach Results in Leak of Confidential Information Provided to PTC Therapeutics, Inc. - JD Supra

Wells Fargo Initiates Coverage of Cencora (COR) with Equal-Weight Recommendation - MSN

Cencora (NYSE:COR) Stock Price Passes Above Two Hundred Day Moving Average of $221.11 - MarketBeat

Cencora (NYSE:COR) Stock Price Crosses Above 200 Day Moving Average of $221.11 - Defense World

Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch

Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch

Cencora discloses data breach in cybersecurity incident - AOL

Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch

Understanding how to energize, extend and capitalize the lifespan of mature drugs - FiercePharma

Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch

Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch

Cencora Inc. Posts Strong Second Quarter Performance, Raises Revenue Guidance for 2024 Fiscal Year - MSN

Cencora Inc. Posts Strong Second Quarter Performance, Raises Revenue Guidance for 2024 Fiscal Year - MSN

Cencora, Inc. (NYSE:COR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Communicator Spotlight: Gina Clark , chief communications and administration officer for Cencora - Axios

Cencora, Inc. (NYSE:COR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Cencora, Inc. (NYSE:COR) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Cencora Inc. Posts Strong Second Quarter Performance, Raises Revenue Guidance for 2024 Fiscal Year - MyChesCo

Cencora Inc. Posts Strong Second Quarter Performance, Raises Revenue Guidance for 2024 Fiscal Year - MyChesCo

Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch

Ex-Dividend Reminder: Essential Utilities, American Electric Power and Cencora - Nasdaq

Cencora (COR) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Lifestyle UK

MSN - MSN

Cencora (NYSE:COR) Downgraded by StockNews.com to Buy - Defense World

Cencora (NYSE:COR) Price Target Raised to $277.00 - Defense World

FY2024 EPS Estimates for Cencora, Inc. (NYSE:COR) Reduced by Leerink Partnrs - Defense World

Nations Financial Group Inc. IA ADV Buys Shares of 13,799 Cencora, Inc. (NYSE:COR) - MarketBeat

There's A Lot To Like About Cencora's (NYSE:COR) Upcoming US$0.51 Dividend - Yahoo Finance

Cencora EVP Gina K. Clark Announces Amicable Retirement - TipRanks.com - TipRanks

Cencora Inc. stock underperforms Friday when compared to competitors - MarketWatch

Unveiling 4 Analyst Insights On Cencora

Oversold Conditions For Cencora (COR) - Nasdaq

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar?

Cencora Second Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Cencora (COR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Cencora shares maintain outperform rating; target cut on Q2 report - Investing.com

Cencora: Fiscal Q2 Earnings Snapshot - Houston Chronicle

Cencora Earnings: Healthy Margins Make Up for Slightly Tempered Sales; Fair Value Estimate Raised - Morningstar

Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Cencora (COR) Q2 Earnings Top Estimates, 2024 View Raised

Cencora stock down premarket as company reports bottom-line miss in Q1 - Investing.com

Cencora (COR) Q2 Earnings Top Estimates

Cencora (COR) Q2 Earnings Top Estimates - Yahoo Finance

Can the 4 Medical Device Stocks Hit Targets This Earnings Season?

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Collaborative partnerships key to clearing the path for new biopharma products - FiercePharma

Cencora (COR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

CORに似た銘柄